QI
AMRI

QS Investors’s Albany Molecular Research Inc AMRI Stock Holding History

QS Investors’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-28
Closed -$1K – 2082
2017
Q1 		$1K Hold
28
– – ﹤0.01% 1977
2016
Q4 		$1K Hold
28
– – ﹤0.01% 1892
2016
Q3 		$1K Buy
28
+8
+40% +$119 ﹤0.01% 1891
2016
Q2 		$1K Buy
+20
New +$292 ﹤0.01% 1956
2016
Q1 		– Sell
-13
Closed -$1K – 2127
2015
Q4 		$1K Buy
+13
New +$247 ﹤0.01% 2001
2014
Q3 		– Sell
-56,700
Closed -$1.14M – 816
2014
Q2 		$1.14M Buy
+56,700
New +$960K 0.03% 355
2014
Q1 		– Sell
-12,600
Closed -$127K – 658
2013
Q4 		$127K Buy
+12,600
New +$152K ﹤0.01% 570

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

QS Investors's AMRI Position: Q2 2017 in Review

QS Investors sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 28 shares — an estimated $1K sold.

QS Investors first reported a position in AMRI in Q4 2013 and held it in 7 quarters. The position peaked at $1.14M in Q2 2014. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • QS Investors reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • QS Investors sold 28 Albany Molecular Research Inc shares in Q2 2017, an estimated $1K.
  • QS Investors first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 7 quarters.
  • QS Investors's Albany Molecular Research Inc position peaked at $1.14M in Q2 2014.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on QS Investors's 13F filing for Q2 2017, filed 14 Aug 2017.